Orum Therapeutics오름테라퓨틱
475830 · KOSDAQ · ₩475830 · 오름테라퓨틱
₩16,070▼ ₩40 (0.25%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩24M | ₩21B |
| Operating income | −₩52B | −₩8.3B |
| Net income | −₩42B | −₩5.7B |
| Net income to shareholders | −₩42B | −₩5.7B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩169B | ₩154B |
| Current assets | ₩134B | ₩123B |
| Cash and equivalents | ₩4.1B | ₩20B |
| Total liabilities | ₩38B | ₩32B |
| Current liabilities | ₩16B | ₩32B |
| Borrowings | ₩12B | ₩0 |
| Total equity | ₩131B | ₩122B |
| Shareholders' equity | ₩131B | ₩122B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩36B | −₩11B |
| Free cash flow | −₩36B | −₩11B |
Consolidated where available. Amounts in won.
Also known as: Orum Therapeutics / 오름테라퓨틱 / 475830 / KRX:475830
Source: KRX statistical information